0001179110-17-013548.txt : 20171030 0001179110-17-013548.hdr.sgml : 20171030 20171030211903 ACCESSION NUMBER: 0001179110-17-013548 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171026 FILED AS OF DATE: 20171030 DATE AS OF CHANGE: 20171030 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BISARO PAUL CENTRAL INDEX KEY: 0001237253 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36867 FILM NUMBER: 171163856 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allergan plc CENTRAL INDEX KEY: 0001578845 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CLONSHAUGH BUSINESS AND TECHNOLOGY PARK CITY: COOLOCK, DUBLIN STATE: L2 ZIP: D17 E400 BUSINESS PHONE: (216) 523-5000 MAIL ADDRESS: STREET 1: CLONSHAUGH BUSINESS AND TECHNOLOGY PARK CITY: COOLOCK, DUBLIN STATE: L2 ZIP: D17 E400 FORMER COMPANY: FORMER CONFORMED NAME: Actavis plc DATE OF NAME CHANGE: 20130930 FORMER COMPANY: FORMER CONFORMED NAME: Actavis Ltd DATE OF NAME CHANGE: 20130607 4 1 edgar.xml FORM 4 - X0306 4 2017-10-26 0 0001578845 Allergan plc AGN 0001237253 BISARO PAUL CLONSHAUGH BUSINESS AND TECHNOLOGY PARK, COOLOCK, CO. DUBLIN L2 D17 E400 IRELAND 1 0 0 0 Ordinary Shares, par value $0.0001 2017-10-26 4 M 0 37727 A 271774 D Ordinary Shares, par value $0.0001 120000 I Paul Bisaro LLC Performance Based Restricted Share Unit 2017-10-27 4 M 0 37727 D Ordinary Shares 37727 0 D The reported securities are restricted share units, each of which represents a right to receive one ordinary share of Allergan plc. The restricted share units will vest in equal installments on each of December 31, 2017, December 31, 2018 and December 31, 2019. Each Performance Based Restricted Share Unit or PSU represented a contingent right to receive a number of Ordinary Shares equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and the Reporting Person. Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc. /s/ A. Robert D. Bailey, Attorney-in-Fact for the Reporting Person 2017-10-30